Genomma Lab Internacional SAB de CV (LABB) - Financial and Strategic SWOT Analysis Review

GlobalData, April 2013, Pages: 33

Summary

Genomma Lab Internacional, S.A.B. de C.V. (Genomma Lab) is a pharmaceutical and personal care products companies. It develops, sells and markets a broad range of premium branded products. The product portfolio of the company comprises anti-acne, scar removal ointments, anti-acids, varicose vein treatments, analgesics, anti-fungal, anti-inflammatory, and multivitamins, hemorrhoid treatments, colitis treatment, shampoos, flu treatments and others. It offers its products under 78 different brands, which include Cicatricure, Asepxia, Goicoechea, Dalay, Bengue, Genoprazol, Diabet TX, Goicotabs, Shot B, Siluet 40, SilkaMedic, Nikzon, X Ray, Next, Touch Me, and QG5, among others.

Genomma Lab Internacional SAB de CV Key Recent Developments

Oct 25, 2012: Genomma Lab Reports Revenue Of MXN2.6 Billion In Q3 2012
Jul 26, 2012: Genomma Lab Reports Revenue Of MXN2.1 Billion In Q2 2012
Apr 25, 2012: Genomma Lab Reports Revenue Of MXN1.8 Billion In Q1 2012
Apr 23, 2012: Genomma Lab Launches New Product To Treat Baldness
Feb 23, 2012: Genomma Lab Reports Revenue Of MXN2.7 Billion In Q4 2011

This comprehensive SWOT profile of Genomma Lab Internacional SAB de CV provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

List of Tables
List of Figures
Section 1 - About the Company
Genomma Lab Internacional SAB de CV - Key Facts
Genomma Lab Internacional SAB de CV - Key Employees
Genomma Lab Internacional SAB de CV - Major Products and Services
Genomma Lab Internacional SAB de CV - History
Genomma Lab Internacional SAB de CV - Company Statement
Genomma Lab Internacional SAB de CV - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Genomma Lab Internacional SAB de CV - Business Description
Genomma Lab Internacional SAB de CV - Corporate Strategy
Genomma Lab Internacional SAB de CV - SWOT Analysis
SWOT Analysis - Overview
Genomma Lab Internacional SAB de CV - Strengths
Strength - Strong Financial Performance
Strength - Stragetic Acquisition of Brands
Strength - Global Presence
Genomma Lab Internacional SAB de CV - Weaknesses
Weakness - Huge Debt
Genomma Lab Internacional SAB de CV - Opportunities
Opportunity - Diversified Business Model
Opportunity - Emerging Markets
Opportunity - Market Penetration through Distribution Channels
Genomma Lab Internacional SAB de CV - Threats
Threat - Government Regulations
Threat - Competitive Pressures
Threat - Risk of Product Obsolescence
Genomma Lab Internacional SAB de CV - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Genomma Lab Internacional SAB de CV, Recent Deals Summary
Section 5 – Company’s Recent Developments
Genomma Lab Internacional SAB de CV, Recent Developments
Oct 25, 2012: Genomma Lab Reports Revenue Of MXN2.6 Billion In Q3 2012
Jul 26, 2012: Genomma Lab Reports Revenue Of MXN2.1 Billion In Q2 2012
Apr 25, 2012: Genomma Lab Reports Revenue Of MXN1.8 Billion In Q1 2012
Apr 23, 2012: Genomma Lab Launches New Product To Treat Baldness
Feb 23, 2012: Genomma Lab Reports Revenue Of MXN2.7 Billion In Q4 2011
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Genomma Lab Internacional SAB de CV, Key Facts
Genomma Lab Internacional SAB de CV, Key Employees
Genomma Lab Internacional SAB de CV, Major Products and Services
Genomma Lab Internacional SAB de CV, History
Genomma Lab Internacional SAB de CV, Subsidiaries
Genomma Lab Internacional SAB de CV, Key Competitors
Genomma Lab Internacional SAB de CV, Ratios based on current share price
Genomma Lab Internacional SAB de CV, Annual Ratios
Genomma Lab Internacional SAB de CV, Interim Ratios
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Genomma Lab Internacional SAB de CV, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Genomma Lab Internacional SAB de CV, Performance Chart (2008 - 2012)
Genomma Lab Internacional SAB de CV, Ratio Charts
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013

Panion & Bf Biotech Inc.
Laboratorios Grin, S.A. de C.V.
Atlantis Pharma, S.A. de C.V.
Nucitec, S.A. de C.V.
Microcide, Inc.
Pisa Farmaceutica Mexicana

Customers who bought this item also bought

• Charter Schools - Global Outlook
• eLEARNING - Global Strategic Business Report
• North America – Smart Weapons Markets and Technologies Outlook – 2013-2020
• Education Services - Global Strategic Business Report
• Aerospace and Defense Industry - Global Strategic Business Report
• Sports and Fitness Nutrition - Global Strategic Business Report
• Commercial And Military Flight Simulation - Global Strategic Business Report
• The Global UAV Payload Market 2012-2022
• Private Tutoring - Global Strategic Business Report
• Defense Robotics - Global Strategic Business Report